Prudential plc(PUK)Earnings, Financials & Key Ratios
PUK•NYSE•Insurance & Managed Care
$32.36
$40.8B mkt cap·10.4× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustryLife InsuranceSub-IndustryDiversified global life and asset managers
AboutPrudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as savings products, such as participating, linked, and other traditional products. The company also provides insurance against common critical illnesses, including cancer, stroke, and heart attack; and tropical disease protection, such as dengue, malaria, and measles. It manages assets across equity, fixed income, multi asset, quantitative, and alternative strategies on behalf of institutional and individual investors. Prudential plc provides its products and services through agency sales force, banks, and brokers. The company was founded in 1848 and is headquartered in London, the United Kingdom.Show more
- Revenue$20.65B+153.7%
- Combined Ratio82.2%+29.0%
- Net Income$2.96B+29.5%
- Return on Equity17.14%+37.5%
- Medical Cost Ratio0%
- Operating Margin17.8%-50.9%
- Net Margin14.33%-48.9%
- ROA1.74%+35.8%
- Equity / Assets10.07%-2.0%
- Book Value per Share12.29-10.5%
- Tangible BV/Share9.49-7.8%
- Debt/Equity0.28+11.7%
PUK Key Insights
Prudential plc (PUK) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Share count reduced 5.1% through buybacks
- ✓Trading near 52-week high
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
PUK Price & Volume
Prudential plc (PUK) stock price & volume — 10-year historical chart
Loading chart...
PUK Growth Metrics
Prudential plc (PUK) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-2.98%
5 Years-10.65%
3 Years-
TTM121.04%
Profit CAGR
10 Years-2.52%
5 Years6.92%
3 Years-
TTM977.54%
EPS CAGR
10 Years5.3%
5 Years-6.9%
3 Years-
TTM918.21%
Return on Capital
10 Years4.05%
5 Years1.11%
3 Years1.72%
Last Year2.17%
PUK Recent Earnings
Prudential plc (PUK) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 2/12 qtrs (17%)●Beat Revenue 3/12 qtrs (50%)
Q2 2026Latest
Mar 18, 2026EPS
$2.08
Est $1.42
+46.5%
Revenue
$11.3B
Est $11.3B
+0.0%
Q2 2026
Mar 17, 2026EPS
$1.54
Est $1.42
+8.5%
Revenue
$11.3B
Q2 2025
Mar 19, 2025EPS
$0.99
Est $1.18
-16.4%
Revenue
$6.7B
Q3 2024
Aug 28, 2024EPS
$0.04
Est $0.91
-95.2%
Revenue
$5.3B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 18, 2026 | $2.08vs $1.42+46.5% | $11.3Bvs $11.3B+0.0% |
| Q2 2026 | Mar 17, 2026 | $1.54vs $1.42+8.5% | $11.3B |
| Q2 2025 | Mar 19, 2025 | $0.99vs $1.18-16.4% | $6.7B |
| Q3 2024 | Aug 28, 2024 | $0.04vs $0.91-95.2% | $5.3B |
Based on last 12 quarters of dataView full earnings history →
PUK Peer Comparison
Prudential plc (PUK) competitors in Diversified global life and asset managers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MFC | 67.02B | 39.97 | 17.69 | 9.38% | 6.96% | 11.2% | 0.28 | |
 SLF | 40.44B | 73.02 | 16.13 | 22.29% | 8.95% | 14.59% | 0.87 | |
 EQH | 12.31B | 43.72 | -9.05 | -6.21% | -12.55% | -49.32% | 3.67 | |
 PRU | 34.86B | 100.16 | 9.80 | -14.01% | 5.62% | 10.26% | 0.65 | |
 MET | 52.27B | 80.16 | 16.70 | 10.22% | 4.44% | 11.88% | 0.70 | |
 LNC | 6.41B | 37.62 | 2.04 | 53.61% | 11.43% | 20.18% | 0.77 | |
 AFL | 58.42B | 113.40 | 16.60 | -8.84% | 21% | 13.05% | 0.29 | |
 GL | 12.11B | 154.39 | 10.98 | 3.82% | 19.36% | 20.64% | 0.44 |
Compare PUK vs Peers
Prudential plc (PUK) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
PUK Income Statement
Prudential plc (PUK) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 65.12B | 20.93B | 70.76B | 36.25B | 26.5B | -27.59B | 11.97B | 8.14B | 20.65B |
| Revenue Growth % | 11.49% | -67.86% | 238.14% | -48.77% | -26.89% | -204.11% | 143.39% | -32.01% | 153.68% |
| Medical Costs & Claims | -21.27B | -7.19B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Medical Cost Ratio % | -32.67% | -34.36% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Gross Profit | 86.39B▲ 0% | 28.12B▼ 67.5% | 70.76B▲ 151.7% | 36.25B▼ 48.8% | 26.5B▼ 26.9% | -27.59B▼ 204.1% | 11.97B▲ 143.4% | 8.14B▼ 32.0% | 20.65B▲ 153.7% |
| Gross Margin % | 132.67% | 134.36% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | 20.46% | -67.45% | 151.66% | -48.77% | -26.89% | -204.11% | 143.39% | -32.01% | 153.68% |
| Operating Expenses | 4.68B | 2.26B | 3.79B | 36.25B | 23.82B | -26.95B | 9.87B | 5.19B | 16.97B |
| OpEx / Revenue % | 7.19% | 10.82% | 5.35% | 100% | 89.9% | 97.67% | 82.48% | 63.72% | 82.2% |
| Depreciation & Amortization | 0 | 0 | 0 | 218M | 0 | 0 | 524M | -191M | 0 |
| Combined Ratio % | -25.48% | -23.55% | 5.35% | 100% | 89.9% | 97.67% | 82.48% | 63.72% | 82.2% |
| Operating Income | 60.44B▲ 0% | 18.66B▼ 69.1% | 66.97B▲ 258.8% | 3.03B▼ 95.5% | 2.68B▼ 11.7% | -643M▼ 124.0% | 2.1B▲ 426.1% | 2.95B▲ 40.8% | 3.68B▲ 24.5% |
| Operating Margin % | 92.81% | 89.18% | 94.65% | 8.36% | 10.1% | 2.33% | 17.52% | 36.28% | 17.8% |
| Operating Income Growth % | 11.9% | -69.12% | 258.84% | -95.47% | -11.72% | -124.03% | 426.13% | 40.82% | 24.47% |
| EBITDA | 60.44B | 18.66B | 66.97B | 3.25B | 3B | -233.86M | 2.62B | 2.76B | 3.81B |
| EBITDA Margin % | 92.81% | 89.18% | 94.65% | 8.96% | 11.34% | 0.85% | 21.9% | 33.94% | 18.46% |
| Interest Expense | 574.35M | 547M | 496M | 316M | 328M | 200M | 172M | 171M | 136.13M |
| Non-Operating Income | -17.1B | -6.33B | 111.31M | 30.23M | -328M | -200M | -438M | -171M | -136.13M |
| Pretax Income | 4.45B▲ 0% | 3.45B▼ 22.5% | 1.73B▼ 50.0% | 2.91B▲ 68.4% | 2.68B▼ 8.0% | -643M▼ 124.0% | 2.1B▲ 426.1% | 2.95B▲ 40.8% | 3.68B▲ 24.5% |
| Pretax Margin % | 6.84% | 16.49% | 2.44% | 8.02% | 10.1% | 2.33% | 17.52% | 36.28% | 17.8% |
| Income Tax | 1.22B | 569M | 252.13M | 440M | 462M | 354M | 385M | 538M | 611.48M |
| Effective Tax Rate % | 27.49% | 16.49% | 14.6% | 15.13% | 17.26% | -55.05% | 18.36% | 18.22% | 16.64% |
| Net Income | 2.39B▲ 0% | 3.15B▲ 32.0% | 591.08M▼ 81.3% | 2.12B▲ 258.3% | -2.04B▼ 196.4% | -1.01B▲ 50.7% | 1.7B▲ 268.9% | 2.29B▲ 34.3% | 2.96B▲ 29.5% |
| Net Margin % | 3.67% | 15.07% | 0.84% | 5.84% | -7.71% | 3.65% | 14.21% | 28.07% | 14.33% |
| Net Income Growth % | 0.8% | 31.96% | -81.25% | 258.33% | -196.41% | 50.69% | 268.92% | 34.33% | 29.51% |
| EPS (Diluted) | 1.40▲ 0% | 1.30▼ 7.1% | 1.14▼ 12.3% | 3.26▲ 186.0% | -3.10▼ 195.1% | -1.48▲ 52.3% | 2.48▲ 267.6% | 1.68▼ 32.3% | 2.28▲ 35.7% |
| EPS Growth % | 14.75% | -7.14% | -12.31% | 185.96% | -195.09% | 52.26% | 267.57% | -32.26% | 35.71% |
| EPS (Basic) | 1.40 | 1.30 | 1.14 | 3.26 | -3.10 | -1.48 | 2.48 | 1.68 | 2.30 |
| Diluted Shares Outstanding | 1.28B | 1.29B | 1.29B | 649.25M | 657M | 684M | 686.75M | 1.36B | 1.29B |
PUK Balance Sheet
Prudential plc (PUK) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 668.2B | 647.81B | 454.21B | 516.1B | 188.23B | 160.25B | 174.07B | 181.88B | 157.48B |
| Asset Growth % | 15.11% | -3.05% | -29.88% | 13.62% | -63.53% | -14.87% | 8.62% | 4.49% | -13.41% |
| Total Investment Assets | 423.65B | 511.77B | 443.4B | 227.58B | 163.93B | 137.25B | 151.61B | 157.61B | 142.34B |
| Long-Term Investments | 0 | 0 | 386.31B | 191.55B | 163.93B | 137.25B | 151.61B | 157.61B | 142.34B |
| Short-Term Investments | 0 | 0 | 57.09B | 36.03B | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 247.24M | 5.48B | 1.88B | 4.68B | 5.3B | 4.56B | 16.43B | 18.51B | 9.59B |
| Cash & Equivalents | 328M | 5.48B | 1.88B | 8.02B | 7.17B | 1.81B | 1.59B | 2.44B | 5.72B |
| Receivables | 0 | 0 | 0 | 0 | 2.88B | 2.79B | 0 | 2.21B | 3.88B |
| Other Current Assets | 0 | 0 | -57.7B | -39.37B | -4.75B | -34.71M | 14.84B | 13.86B | 0 |
| Goodwill & Intangibles | 16.9B | 17.55B | 13.92B | 21.31B | 4.92B | 4.77B | 4.88B | 4.67B | 3.61B |
| Goodwill | 1.48B | 1.86B | 731.49M | 961M | 907M | 890M | 896M | 848M | 669.43M |
| Intangible Assets | 11.01B | 11.72B | 13.19B | 20.34B | 4.01B | 3.88B | 3.99B | 3.82B | 2.94B |
| PP&E (Net) | 594.73M | 1.05B | 803.96M | 893M | 495M | 437M | 374M | 417M | 393.35M |
| Other Assets | 354.58B | 354.11B | 326.27B | 154.11B | -27.56B | -14.61B | -157.02B | 16.82B | 1.46B |
| Total Liabilities | 646.43B | 625.82B | 434.55B | 493.98B | 169.12B | 143.35B | 156.08B | 163.2B | 141.63B |
| Total Debt | 7.59B | 6.17B | 5.35B | 9.08B | 8.24B | 5.08B | 4.87B | 4.72B | 4.48B |
| Net Debt | 7.34B | 687.14M | 3.47B | 1.06B | 1.07B | 3.27B | 3.28B | 2.28B | -1.24B |
| Long-Term Debt | 7.59B | 6.17B | 5.35B | 7.67B | 6.99B | 3.92B | 3.94B | 3.94B | 4.48B |
| Short-Term Debt | 0 | 0 | 912M | 907M | 904M | 862M | 699M | 527M | 0 |
| Total Current Liabilities | 726M | 14.23B | 490.68M | 18.43B | 474.74M | 3.21B | 5.93B | 4.35B | 0 |
| Accounts Payable | 0 | 3.01B | 2.83B | 1.28B | 1.12B | 2.87B | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | -726M | 0 | -11.45B | -907M | -614.26M | -528M | 1.17B | 976M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 351.52B | 351.26B | 322.19B | 341.71B | 127.52B | 114.15B | -5.42B | -5.71B | 135.79B |
| Total Equity | 21.77B▲ 0% | 21.99B▲ 1.0% | 19.67B▼ 10.6% | 22.12B▲ 12.5% | 19.11B▼ 13.6% | 16.9B▼ 11.6% | 17.98B▲ 6.4% | 18.67B▲ 3.8% | 15.85B▼ 15.1% |
| Equity Growth % | 48.43% | 1.01% | -10.56% | 12.46% | -13.6% | -11.58% | 6.42% | 3.84% | -15.11% |
| Shareholders Equity | 21.76B | 21.97B | 14.7B | 20.88B | 18.94B | 16.73B | 17.82B | 17.49B | 14.93B |
| Minority Interest | 9M | 23M | 192M | 1.24B | 175M | 167M | 160M | 1.18B | 922.5M |
| Retained Earnings | 9.48B | 21.82B | 10.39B | 14.42B | 12.06B | 10.65B | 11.93B | 11.91B | 10.45B |
| Common Stock | 174.33M | 97M | 129.84M | 173M | 182M | 182M | 183M | 176M | 125.42M |
| Accumulated OCI | 0 | -1.97B | 2.34B | 3.64B | 1.68B | 890M | 703M | 401M | 631.58M |
| Return on Equity (ROE) | 13.11% | 14.41% | 2.84% | 10.14% | -9.91% | -5.59% | 9.75% | 12.47% | 17.14% |
| Return on Assets (ROA) | 0.38% | 0.48% | 0.11% | 0.44% | -0.58% | -0.58% | 1.02% | 1.28% | 1.74% |
| Equity / Assets | 3.26% | 3.39% | 4.33% | 4.29% | 10.15% | 10.54% | 10.33% | 10.27% | 10.07% |
| Debt / Equity | 0.35x | 0.28x | 0.27x | 0.41x | 0.43x | 0.30x | 0.27x | 0.25x | 0.28x |
| Book Value per Share | 16.96 | 17.07 | 15.21 | 34.07 | 29.09 | 24.70 | 26.19 | 13.73 | 12.29 |
| Tangible BV per Share | 7.23 | 6.53 | 4.44 | 1.25 | 21.60 | 17.73 | 19.08 | 10.30 | 9.49 |
PUK Cash Flow Statement
Prudential plc (PUK) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 1.22B | 2.64B | -4.01B | 2.5B | 278M | 1.08B | 832M | 3.61B | 1.69B |
| Operating CF Growth % | -31.88% | 115.84% | -252.03% | 162.35% | -88.87% | 287.77% | -22.82% | 333.77% | -53.13% |
| Operating CF / Revenue % | 1.88% | 12.59% | -5.66% | 6.89% | 1.05% | -3.91% | 6.95% | 44.34% | 8.19% |
| Net Income | 2.39B | 3.15B | 591.08M | 3.18B | 3.02B | -833.01M | 2.27B | 3.24B | 2.96B |
| Depreciation & Amortization | 217.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 119.1M | 149.83M | 136.64M | 0 | 73.95M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 381.87M | -350.93M | -3.23B | -7.53B | 2.63B | 22.35B | -14.23B | 163.91M | -267.8M |
| Working Capital Changes | -1.89B | -315.84M | -1.51B | 6.85B | -5.44B | -20.44B | 12.79B | 206.09M | -999.79M |
| Cash from Investing | 615.08M | -615.33M | -587.3M | -1.2B | -726M | -39M | -360M | -832M | 809.36M |
| Capital Expenditures | -134M | -78.23M | -48.31M | -57M | -36M | -27.6M | -44M | -101M | -77.37M |
| Acquisitions | -264.57M | -258.04M | -479.36M | -1.14B | -690M | -5M | -142M | -557M | 886.72M |
| Purchase of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sale/Maturity of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing | 1.01B | -279.06M | -59.64M | -3.28M | 0 | -6.4M | -174M | -174M | 0 |
| Cash from Financing | -1.28B | -659M | -1.96B | 36.28M | 1.26B | -2.52B | -1.21B | -1.7B | -1.17B |
| Dividends Paid | -1.57B | -1.3B | -1.23B | -814M | -421M | -474M | -533M | -552M | -441.87M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -4M | 0 | -860M | -931.36M |
| Stock Issued | 28.38M | 23M | 22M | 13M | 2.38B | 0 | 4M | 0 | 1.49M |
| Debt Issuance (Net) | -1000K | 1000K | -1000K | 1000K | -1000K | -1000K | -1000K | 0 | 1000K |
| Other Financing | 506.34M | -575.32M | -539.85M | -145.72M | -420.18M | -313M | -288M | -283M | -138.36M |
| Net Change in Cash | 844.63M▲ 0% | 1.06B▲ 25.4% | -6.86B▼ 747.2% | 1.05B▲ 115.4% | 773M▼ 26.6% | -1.66B▼ 314.2% | -763M▲ 53.9% | 1.02B▲ 233.8% | 1.44B▲ 40.6% |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 1000K |
| Cash at Beginning | 13.6B | 14.46B | 12.11B | 6.96B | 8.02B | 7.17B | 5.51B | 4.75B | 4.28B |
| Cash at End | 14.45B | 15.44B | 5.26B | 8.02B | 7.17B | 5.51B | 4.75B | 5.77B | 5.72B |
| Free Cash Flow | 1.12B▲ 0% | 3.22B▲ 187.6% | -4.06B▼ 225.9% | 2.44B▲ 160.2% | 242M▼ 90.1% | 839.48M▲ 246.9% | 788M▼ 6.1% | 3.51B▲ 345.2% | 1.61B▼ 54.0% |
| FCF Growth % | -51.01% | 187.56% | -225.9% | 160.19% | -90.09% | 246.89% | -6.13% | 345.18% | -53.98% |
| FCF Margin % | 1.72% | 15.39% | -5.73% | 6.73% | 0.91% | -3.04% | 6.58% | 43.1% | 7.82% |
| FCF per Share | 0.87 | 2.5 | -3.14 | 3.76 | 0.37 | 1.23 | 1.15 | 2.58 | 1.25 |
PUK Key Ratios
Prudential plc (PUK) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | -15.26% | -25.48% | -23.55% | 5.35% | 100% | 89.9% | 97.67% | 82.48% | 63.72% | 82.2% |
| Medical Cost Ratio | -22.78% | -32.67% | -34.36% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Return on Equity (ROE) | 14% | 13.11% | 14.41% | 2.84% | 10.14% | -9.91% | -5.59% | 9.75% | 12.47% | 17.14% |
| Return on Assets (ROA) | 0.41% | 0.38% | 0.48% | 0.11% | 0.44% | -0.58% | -0.58% | 1.02% | 1.28% | 1.74% |
| Equity / Assets | 2.53% | 3.26% | 3.39% | 4.33% | 4.29% | 10.15% | 10.54% | 10.33% | 10.27% | 10.07% |
| Book Value / Share | 11.45 | 16.96 | 17.07 | 15.21 | 34.07 | 29.09 | 24.7 | 26.19 | 13.73 | 12.29 |
| Debt / Equity | 0.47x | 0.35x | 0.28x | 0.27x | 0.41x | 0.43x | 0.30x | 0.27x | 0.25x | 0.28x |
| Revenue Growth | 108.97% | 11.49% | -67.86% | 238.14% | -48.77% | -26.89% | -204.11% | 143.39% | -32.01% | 153.68% |
PUK Frequently Asked Questions
Prudential plc (PUK) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Prudential plc (PUK) grew revenue by 153.7% over the past year. This is strong growth.
Yes, Prudential plc (PUK) is profitable, generating $5.53B in net income for fiscal year 2025 (14.3% net margin).
Dividend & Returns
Yes, Prudential plc (PUK) pays a dividend with a yield of 1.44%. This makes it attractive for income-focused investors.
Prudential plc (PUK) has a return on equity (ROE) of 17.1%. This is reasonable for most industries.
Industry Metrics
Prudential plc (PUK) has a combined ratio of 0.0%. A ratio below 100% indicates underwriting profitability.
Explore More PUK
Prudential plc (PUK) financial analysis — history, returns, DCA and operating performance tools
Full PUK Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates